BI Asset Management Fondsmaeglerselskab A S Takes $7.03 Million Position in Encompass Health Corporation $EHC

Key Points

• BI Asset Management Fondsmaeglerselskab A S opened a new position in Encompass Health, buying 72,675 shares worth about $7.03 million in the first quarter.
• Encompass Health recently beat quarterly expectations, reporting $1.60 EPS on $1.59 billion in revenue, both above analyst estimates, and raised its FY 2026 guidance to 5.890–6.110 EPS.
• The stock has drawn mostly positive analyst sentiment, with a consensus Buy rating and an average price target of $143.86; the company also declared a quarterly dividend of $0.19 per share.

BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Encompass Health Corporation (NYSE:EHC - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 72,675 shares of the company's stock, valued at approximately $7,030,000. BI Asset Management Fondsmaeglerselskab A S owned approximately 0.07% of Encompass Health at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of EHC. EP Wealth Advisors LLC lifted its stake in shares of Encompass Health by 2.4% in the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company's stock valued at $453,000 after purchasing an additional 88 shares during the period. Allworth Financial LP increased its holdings in Encompass Health by 14.7% in the third quarter. Allworth Financial LP now owns 701 shares of the company's stock valued at $89,000 after buying an additional 90 shares in the last quarter. Leuthold Group LLC increased its holdings in Encompass Health by 0.3% in the fourth quarter. Leuthold Group LLC now owns 31,168 shares of the company's stock valued at $3,308,000 after buying an additional 104 shares in the last quarter. Covestor Ltd lifted its position in shares of Encompass Health by 24.4% during the 4th quarter. Covestor Ltd now owns 540 shares of the company's stock valued at $57,000 after acquiring an additional 106 shares during the period. Finally, Benjamin Edwards Inc. boosted its stake in shares of Encompass Health by 1.4% during the 4th quarter. Benjamin Edwards Inc. now owns 8,008 shares of the company's stock worth $850,000 after acquiring an additional 112 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Analyst Ratings Changes

EHC has been the subject of several research analyst reports. TD Cowen initiated coverage on Encompass Health in a research note on Thursday, May 28th. They issued a "buy" rating and a $125.00 price objective for the company. Leerink Partners set a $152.00 target price on Encompass Health in a research report on Friday, May 22nd. Barclays lowered their target price on Encompass Health from $153.00 to $140.00 and set an "overweight" rating on the stock in a report on Tuesday, May 5th. Weiss Ratings restated a "buy (b-)" rating on shares of Encompass Health in a research report on Monday, June 8th. Finally, Wall Street Zen raised Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, May 2nd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $143.86.

Encompass Health Stock Performance

NYSE EHC opened at $97.94 on Monday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The business has a fifty day moving average of $103.92 and a 200-day moving average of $103.98. The stock has a market cap of $9.72 billion, a price-to-earnings ratio of 16.35, a price-to-earnings-growth ratio of 2.14 and a beta of 0.72.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping analysts' consensus estimates of $1.51 by $0.09. The firm had revenue of $1.59 billion during the quarter, compared to analysts' expectations of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm's quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, analysts predict that Encompass Health Corporation will post 5.97 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health's payout ratio is presently 12.69%.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the business's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. The trade was a 2.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.80% of the company's stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.